Use of the Michigan Neuropathy Screening Instrument (MNSI) for the detection of peripheral neuropathy in diabetic patients who come to USFA - Minga Pora

Abstract

Introduction: Peripheral neuropathy triggered by diabetes mellitus represents a state of vulnerability for the quality of life of patients. Objective: Determine the usefulness of the Michigan Neuropathy Screening Instrument (MNSI) for the detection of peripheral neuropathy in diabetic patients who attend the USFA - Minga Pora between June to September 2023. Material and Methods: Due to this, an observational, cross-sectional and descriptive study was carried out on the use of the Michigan Neuropathy Screening Instrument (MNSI) for the detection of peripheral neuropathy in diabetic patients who attend the USFA - Minga Pora between June and September 2023. The MNSI consists of 15 closed questions and 5 physical examination parameters, gender was added to this test. Results: In the study carried out, it was observed that 73% (8) of the population correspond to patients with neuropathy and 27% (3) to patients without neuropathy. Conclusion: The use of the Michigan Neuropathy Screening Instrument (MNSI) is postulated as an easy-to-use tool for primary care since the material necessary for its application is easy to access, quick to assess, and serves as a screening element. for peripheral neuropathy in diabetic patients, from which timely referral to the next level of health care can be made.